Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature
- PMID: 33524611
- DOI: 10.1016/j.wneu.2021.01.019
Endoscopic Endonasal Approach to Giant Pituitary Adenomas: Surgical Outcomes and Review of the Literature
Abstract
Objective: To present the outcomes of endoscopic endonasal surgery for giant pituitary adenomas and discuss the extent of resection to minimize morbidity and mortality.
Methods: We retrospectively reviewed medical records of 44 patients with giant pituitary adenomas who underwent endoscopic endonasal surgery. Clinical presentation, laboratory results, imaging studies, clinical outcomes, extent of resection, and complications were collected and analyzed. Factors affecting long-term outcome according to surgical technique were identified and analyzed.
Results: Radical resection (RR) was defined as either gross total resection or near-total resection (90%-100% of the tumor). There were 28 patients (63.6%) who underwent RR, 10 patients (22.7%) who underwent subtotal resection, and 6 patients (13.6%) who underwent partial resection. Visual improvement was achieved in 27 patients (81.8%). Thirteen patients (72.2%) with pituitary dysfunction had improvement in at least 1 preoperative endocrinological dysfunction. RR rates for dumbbell and multilobular tumors were 44.4% and 28.6%, respectively. Surgical complications were observed in 14 (31.8%) patients. Major vascular injury occurred in 3 patients (6.8%). Mean follow-up period was 38.5 months (range, 1-70 months). No patients with RR had recurrence or residual tumor progression. Ten patients (22.7%) received adjuvant radiation therapy after resection. Two patients were reoperated on for tumor regrowth, and 3 patients (including the 2 patients with tumor regrowth) were lost to follow-up.
Conclusions: Long-term follow-up results and low recurrence rate of tumors indicate that RR is effective to decrease morbidity and mortality.
Keywords: Endoscopic endonasal surgery; Giant pituitary adenoma; Gross total resection; Radical resection; Surgical outcomes.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Endoscopic Endonasal Surgery for Tumors of the Cavernous Sinus: A Series of 234 Patients.World Neurosurg. 2017 Jul;103:713-732. doi: 10.1016/j.wneu.2017.04.096. Epub 2017 Apr 24. World Neurosurg. 2017. PMID: 28450229
-
Efficacy and Complications of Endoscopic Skull Base Surgery for Giant Pituitary Adenomas.World Neurosurg. 2017 Mar;99:533-542. doi: 10.1016/j.wneu.2016.12.068. Epub 2016 Dec 23. World Neurosurg. 2017. PMID: 28024972
-
Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study.Childs Nerv Syst. 2019 Nov;35(11):2119-2126. doi: 10.1007/s00381-019-04179-z. Epub 2019 May 11. Childs Nerv Syst. 2019. PMID: 31079182
-
Current Results of Surgical Treatment of Craniopharyngiomas: The Impact of Endoscopic Endonasal Approaches.World Neurosurg. 2020 Oct;142:582-592. doi: 10.1016/j.wneu.2020.05.174. World Neurosurg. 2020. PMID: 32987614 Review.
-
Pediatric pituitary adenomas.Childs Nerv Syst. 2019 Nov;35(11):2107-2118. doi: 10.1007/s00381-019-04293-y. Epub 2019 Jul 13. Childs Nerv Syst. 2019. PMID: 31302729 Review.
Cited by
-
Endoscope-assisted transcranial surgery for complex pituitary adenoma: a retrospective case series study with propensity score matching.Neurosurg Rev. 2025 Jan 16;48(1):53. doi: 10.1007/s10143-025-03189-7. Neurosurg Rev. 2025. PMID: 39814956
-
Endoscopic resection of supergiant pituitary adenoma.Surg Neurol Int. 2021 Oct 25;12:535. doi: 10.25259/SNI_630_2021. eCollection 2021. Surg Neurol Int. 2021. PMID: 34754585 Free PMC article.
-
MemoBox: A mechanical follow-the-leader system for minimally invasive surgery.Front Med Technol. 2022 Sep 13;4:938643. doi: 10.3389/fmedt.2022.938643. eCollection 2022. Front Med Technol. 2022. PMID: 36340589 Free PMC article.
-
A Comprehensive Review of the Role of the Latest Minimally Invasive Neurosurgery Techniques and Outcomes for Brain and Spinal Surgeries.Cureus. 2025 May 23;17(5):e84682. doi: 10.7759/cureus.84682. eCollection 2025 May. Cureus. 2025. PMID: 40546558 Free PMC article. Review.
-
Outcome of Endoscopic Transsphenoidal Surgery for Recurrent or Residual Pituitary Adenomas and Comparison to Non-Recurrent or Residual Cohort by Propensity Score Analysis.Front Endocrinol (Lausanne). 2022 Apr 25;13:837025. doi: 10.3389/fendo.2022.837025. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35547003 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical